Annual Accounts Payable
$13.05 M
+$6.58 M+101.64%
December 31, 2023
Summary
- As of February 8, 2025, BCYC annual accounts payable is $13.05 million, with the most recent change of +$6.58 million (+101.64%) on December 31, 2023.
- During the last 3 years, BCYC annual accounts payable has risen by +$11.69 million (+856.04%).
- BCYC annual accounts payable is now at all-time high.
Performance
BCYC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.71 M
-$1.74 M-23.33%
September 30, 2024
Summary
- As of February 8, 2025, BCYC quarterly accounts payable is $5.71 million, with the most recent change of -$1.74 million (-23.33%) on September 30, 2024.
- Over the past year, BCYC quarterly accounts payable has dropped by -$1.74 million (-23.33%).
- BCYC quarterly accounts payable is now -56.21% below its all-time high of $13.05 million, reached on December 31, 2023.
Performance
BCYC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BCYC Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +101.6% | -23.3% |
3 y3 years | +856.0% | -23.3% |
5 y5 years | +591.6% | -23.3% |
BCYC Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +379.6% | -56.2% | +110.0% |
5 y | 5-year | at high | +856.0% | -56.2% | +473.7% |
alltime | all time | at high | +856.0% | -56.2% | +473.7% |
Bicycle Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.71 M(-23.3%) |
Jun 2024 | - | $7.45 M(+5.6%) |
Mar 2024 | - | $7.06 M(-45.9%) |
Dec 2023 | $13.05 M(+101.6%) | $13.05 M(+53.7%) |
Sep 2023 | - | $8.49 M(+61.8%) |
Jun 2023 | - | $5.25 M(+86.6%) |
Mar 2023 | - | $2.81 M(-56.5%) |
Dec 2022 | $6.47 M(+137.9%) | $6.47 M(-8.3%) |
Sep 2022 | - | $7.06 M(+45.2%) |
Jun 2022 | - | $4.86 M(+21.5%) |
Mar 2022 | - | $4.00 M(+47.0%) |
Dec 2021 | $2.72 M | $2.72 M(+54.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $1.76 M(-49.3%) |
Jun 2021 | - | $3.47 M(+248.5%) |
Mar 2021 | - | $996.00 K(-27.0%) |
Dec 2020 | $1.36 M(-30.0%) | $1.36 M(-33.6%) |
Sep 2020 | - | $2.06 M(-38.4%) |
Jun 2020 | - | $3.34 M(-24.7%) |
Mar 2020 | - | $4.43 M(+127.5%) |
Dec 2019 | $1.95 M(+3.3%) | $1.95 M(-2.2%) |
Sep 2019 | - | $1.99 M(-22.5%) |
Jun 2019 | - | $2.57 M(+14.6%) |
Mar 2019 | - | $2.24 M(+18.8%) |
Dec 2018 | $1.89 M(-8.6%) | $1.89 M |
Dec 2017 | $2.06 M | - |
FAQ
- What is Bicycle Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual accounts payable year-on-year change?
- What is Bicycle Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly accounts payable year-on-year change?
What is Bicycle Therapeutics annual accounts payable?
The current annual accounts payable of BCYC is $13.05 M
What is the all time high annual accounts payable for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual accounts payable is $13.05 M
What is Bicycle Therapeutics annual accounts payable year-on-year change?
Over the past year, BCYC annual accounts payable has changed by +$6.58 M (+101.64%)
What is Bicycle Therapeutics quarterly accounts payable?
The current quarterly accounts payable of BCYC is $5.71 M
What is the all time high quarterly accounts payable for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly accounts payable is $13.05 M
What is Bicycle Therapeutics quarterly accounts payable year-on-year change?
Over the past year, BCYC quarterly accounts payable has changed by -$1.74 M (-23.33%)